== Appearance of histone H3, cyclin E and cdc25C in HT29 cells after MMR recognition of 5-FU

== Appearance of histone H3, cyclin E and cdc25C in HT29 cells after MMR recognition of 5-FU. cyclins E1 and E2 (1.4-fold) and downregulated cdc25C, cyclins B1 and B2, histone H2A, H2B and H3 (-1.4-fold) over control. Cell cycle analysis revealed a G1/S arrest by 5-FU that was congruent with increased cyclin E and decreased cdc25C protein expression. Importantly, with knockdown ofhMLH1andhMSH2, we observed that decreased histone H3 expression by 5-FU was dependent onhMLH1. Additionally, 5-FU treatment dramatically decreased levels of several histone H3 modifications. Our data suggest that 5-FU induces a G1/S arrest by regulating cyclin E and cdc25C expression and MMR recognition of 5-FU in DNA may modulate cyclin E to affect the cell cycle. Furthermore, MMR recognition of 5-FU reduces histone H3 levels that could be related to DNA access by proteins and/or cell death during the G1/S Tirofiban Hydrochloride Hydrate phase of the cell cycle. Key words:5-fluorouracil, colorectal cancer, DNA mismatch repair, cyclin E, histone H3, cancer treatment, microsatellite instability == Introduction == 5-fluorouracil (5-FU) is the principal chemotherapeutic agent used to treat patients with advanced colorectal cancer. In particular, 5-FU-based chemotherapy improves survival in patients with stage III colon cancer,13and in patients with stage II and III rectal cancer.4Although 5-FU based chemotherapy is the gold standard for advanced stage colorectal cancer patients, individual patient tumor Tirofiban Hydrochloride Hydrate response rate for 5-FU treatment is low (2030%) but it does have an impact on survival.5,6There is no current methodology to decide which advanced colorectal cancer patient will have a tumor response to 5-FU treatment. However, loss of DNA mismatch repair (MMR) within the patient’s tumor is usually associated with no survival benefit from 5-FU treatment.7,8 Functional MMR requires hMutS (a heterodimer of hMSH2 and hMSH6) and hMutS (a heterodimer of hMSH2 and hMSH3) to recognize and bind mispairs and/or insertion/deletion loops (IDLs) that occur at microsatellite sequences. hMutL (a heterodimer of hMLH1 and hPMS2) joins the hMutS complexes to help coordinate DNA excision Tirofiban Hydrochloride Hydrate and repair of the mispair or IDL.911Defects in the MMR geneshMSH2, hMLH1, hMSH6orhPMS2cause Lynch syndrome and epigenetic inactivation ofhMLH1by promoter hypermethylation occurs in 1520% of sporadic colorectal tumors with microsatellite instability (MSI).1217 Retrospective and prospective studies of patients with colorectal cancer indicate that those with intact MMR in Rabbit polyclonal to CD24 (Biotin) their tumors have improved survival with 5-FU treatment, whereas patients whose tumors lost MMR do not have improved survival.7,8,18In vitro studies revealed that human colorectal cell lines with intact MMR were selectively killed with 5-FU treatment whereas MSI cells were resistant to 5-FU treatment.19Additionally, biochemical studies demonstrated that hMutS directly recognizes and binds 5-FU that is incorporated into DNA with a greater affinity compared to its natural substrate, a base mispair and such recognition was lost with MMR deficiency.20,21These observations suggest that MMR, at least in part, mediates the cytotoxicity of 5-FU in addition to its known roles affecting RNA.20 It is not clear how the MMR system recognizes 5-FU incorporated into DNA, although the human MMR system can recognize certain DNA adducts such as 6-thioguanine (6-TG) and O6-methylguanine (O6-MeG) caused by alkylation damage.22,23The downstream signaling pathways triggered by MMR recognition of modified DNA have been partially elucidated for some chemotherapeutic agents. For example, incorporation or formation of O6-MeG into DNA induces DNA mispairing and distorts the DNA double helix that is easily detected by the MMR system.2224Introduction of O6-MeG into DNA results in a G2/M cell cycle arrest and apoptosis that are dependent on an intact MMR system and involve the ATM and Rad3-related (ATR) signaling pathway as well as mitochondrial signaling that activates both caspase-dependent and caspase-independent pathways.2527However, the signaling pathways triggered by MMR in response to 5-FU-modified DNA have not been elucidated. We aimed to elucidate key signaling pathways upon MMR recognition of 5-FU that result in slowing of the cell cycle and cell death. In this study, we utilized a whole human genomic cDNA microarray analysis to examine relative signaling responses induced in MMR-proficient colorectal cancer cells in response to 5-FU. We verified microarray observations with protein expression of each gene affected by.